MEDLINE (OvidSP) | |
#1 | deferasirox*.mp. |
#2 | (ICL670* or ICL 670*).mp. |
#3 | (CGP72670* or CGP 72670*).mp. |
#4 | exjade*.mp. |
#5 | 2‐hydroxyphenyl.mp. |
#6 | triazol‐1‐yl.mp. |
#7 | benzoic acid.mp. |
#8 | 5 and 6 and 7 |
#9 | 1 or 2 or 3 or 4 or 8 |
#10 | (2010* or 2011* or 2012* or 2013* or 2014*).ed,ep,dc. or ("2010" or "2011" or "2012" or "2013" or "2014").yr. |
#11 | 9 and 10 |
#12 | randomized controlled trial.pt. |
#13 | controlled clinical trial.pt. |
#14 | randomi#ed.ab. |
#15 | placebo.ab. |
#16 | drug therapy.fs. |
#17 | randomly.ab. |
#18 | trial.ab. |
#19 | groups.ab. |
#20 | 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 |
#21 | exp animals/ not humans.sh. |
#22 | 20 not 21 |
#23 | 11 and 22 |
Notes .mp. = title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier. .sh. or / = Medical Subject Heading exp = explode .ti. title .ab. = abstract .pt. = publication type .yr. = year .ed. = entry date .ep. = electronic date of publication .dc. = date created | |
MEDLINE Daily Update (OvidSP) | |
#1 | deferasirox*.mp. |
#2 | (ICL670* or ICL 670*).mp. |
#3 | (CGP72670* or CGP 72670*).mp. |
#4 | exjade*.mp. |
#5 | 2‐hydroxyphenyl.mp. |
#6 | triazol‐1‐yl.mp. |
#7 | benzoic acid.mp. |
#8 | 5 and 6 and 7 |
#9 | 1 or 2 or 3 or 4 or 8 |
Notes .mp. = title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier. | |
MEDLINE In‐Process & Other Non‐Indexed Citations (OvidSP) | |
#1 | deferasirox*.mp. |
#2 | (ICL670* or ICL 670*).mp. |
#3 | (CGP72670* or CGP 72670*).mp. |
#4 | exjade*.mp. |
#5 | 2‐hydroxyphenyl.mp. |
#6 | triazol‐1‐yl.mp. |
#7 | benzoic acid.mp. |
#8 | 5 and 6 and 7 |
#9 | 1 or 2 or 3 or 4 or 8 |
Notes .mp. = title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier. | |
PubMed – subset "supplied by publisher" (www.pubmed.gov) | |
#1 | Search deferasirox*[tw] |
#2 | Search ICL670*[tw] OR ICL 670*[tw] |
#3 | Search CGP72670*[tw] OR CGP 72670*[tw] |
#4 | Search exjade*[tw] |
#5 | Search 2‐hydroxyphenyl[tw] |
#6 | Search triazol‐1‐yl[tw] |
#7 | Search benzoic acid[tw] |
#8 | Search #5 AND #6 AND #7 |
#9 | Search #1 OR #2 OR #3 OR #4 OR #8 |
#10 | Search #9 AND publisher[sb] |
Notes [tw] = textword: title, abstract, other abstract, MeSH terms, MeSH Subheadings, Publication Types, Substance Names, Personal Name as Subject, Corporate Author, Secondary Source, and Other Terms. [sb] = subset | |
EMBASE and EMBASE Alert (DIMDI www.dimdi.de) | |
#1 | EM05; EA08 |
#2 | FT=DEFERASIROX* |
#3 | FT=ICL670* OR FT=ICL 670* |
#4 | FT=CGP72670* OR FT=CGP 72670* |
#5 | FT=EXJADE* |
#6 | FT=2‐HYDROXYPHENYL |
#7 | FT=TRIAZOL‐1‐YL |
#8 | FT=BENZOIC ACID |
#9 | 6 AND 7 AND 8 |
#10 | 2 OR 3 OR 4 OR 5 OR 9 |
#11 | 10 AND PY>=2010 |
#12 | (FT=RANDOM* OR FT=PLACEBO* ) OR FT=DOUBLE‐BLIND* |
#13 | 11 AND 12 |
#14 | 13 NOT SU=MEDLINE |
Notes EM05 = EMBASE ab 2005; EA08 = EMBASE Alert PY = Publication year SU = subunit | |
The Cochrane Library (Wiley: www.thecochranelibrary.com) | |
#1 | deferasirox* |
#2 | ICL670* OR (ICL next 670*) |
#3 | CGP72670* OR (CGP next 72670*) |
#4 | exjade* |
#5 | 2 next hydroxyphenyl |
#6 | triazol next 1 next yl |
#7 | benzoic next acid |
#8 | (#5 AND #6 AND #7) |
#9 | (#1 OR #2 OR #3 OR #4 OR #8) |
#10 | #9 Publication Date from 2010 to 2014 (Word variations have been searched) |
Biosis Previews (Thomson Reuters) | |
#1 | ts=deferasirox* |
#2 | ts=(ICL670* or "ICL 670*") |
#3 | ts=(CGP72670* or "CGP 72670*") |
#4 | ts=exjade* |
#5 | ts="2‐hydroxyphenyl" |
#6 | ts="triazol‐1‐yl" |
#7 | ts="benzoic acid" |
#8 | #7 AND #6 AND #5 |
#9 | #8 OR #4 OR #3 OR #2 OR #1 |
#10 | ts=(rando* or placebo or trial or "single‐blind*" or "double‐blind*" or groups) |
#11 | #10 AND #9 |
Notes Ts = topic:
Indexes = BIOSIS Previews Timespan = 2010 to 2014 | |
Web of Science via Web of Knowledge (Thomson Reuters) | |
#1 | ts=deferasirox* |
#2 | ts=(ICL670* or "ICL 670*") |
#3 | ts=(CGP72670* or "CGP 72670*") |
#4 | ts=exjade* |
#5 | ts="2‐hydroxyphenyl" |
#6 | ts="triazol‐1‐yl" |
#7 | ts="benzoic acid" |
#8 | #7 AND #6 AND #5 |
#9 | #8 OR #4 OR #3 OR #2 OR #1 |
#10 | ts=(rando* or placebo or trial or "single‐blind*" or "double‐blind*" or groups) |
#11 | #10 AND #9 |
Notes TS = topic: Title, Abstract, Author Keywords, Keywords Plus® Indexes = SCI‐EXPANDED, SSCI, A&HCI, CPCI‐S, CPCI‐SSH Timespan = 2010 to 2014 | |
Derwent Drug file (DIMDI www.dimdi.de) | |
#1 | DD83 |
#2 | DEFERASIROX* |
#3 | FT=ICL670* OR FT=ICL 670* |
#4 | FT=CGP72670* OR FT=CGP 72670* |
#5 | FT=EXJADE* |
#6 | FT=2‐HYDROXYPHENYL |
#7 | FT=TRIAZOL‐1‐YL |
#8 | FT=BENZOIC ACID |
#9 | 6 AND 7 AND 8 |
#10 | 2 OR 3 OR 4 OR 5 OR 9 |
#11 | 10 AND PY>=2010 |
#12 | ((((FT=RANDO* OR FT=PLACEBO ) OR FT=TRIAL ) OR (CT D "SINGLE‐BLIND"* OR UT="SINGLE‐BLIND"* OR IT="SINGLE‐BLIND"* OR SH="SINGLE‐BLIND"*)) OR FT=DOUBLE‐BLIND* ) OR FT=GROUPS |
#13 | 11 AND 12 |
Notes DD83 = Derwent Drug File PY = Publication year |